Patents by Inventor Darrell Johnstone

Darrell Johnstone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10117933
    Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin B. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: November 6, 2018
    Assignee: EMERGENT BIOSOLUTIONS CANADA INC.
    Inventors: Jody Berry, Cory Nykiforuk, Darrell Johnstone, Joyee Antony George
  • Patent number: 9994630
    Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: June 12, 2018
    Assignee: CANGENE CORPORATION
    Inventors: Jody Berry, Darrell Johnstone, Joyee Antony George, Bonnie Tighe
  • Publication number: 20180030118
    Abstract: The present disclosure relates to an antibody or antigen-binding portion thereof that binds to a filovirus. The antibody or antigen-binding portion thereof may have one or more murine CDRs and one or more human framework, regions. Also provided herein are compositions comprising the antibody or antigen-binding portion t hereof, methods of producing the antibody or antigen-binding portion thereof and methods of using the antibody or antigen-binding portion thereof.
    Type: Application
    Filed: February 19, 2016
    Publication date: February 1, 2018
    Applicant: Emergent BioSolutions Canada Inc.
    Inventor: Darrell JOHNSTONE
  • Publication number: 20170051047
    Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.
    Type: Application
    Filed: October 31, 2016
    Publication date: February 23, 2017
    Inventors: Jody Berry, Darrell Johnstone, Joyee Antony George, Bonnie Tighe
  • Publication number: 20170008955
    Abstract: Provided herein are humanized antibodies or antigen-binding fragments thereof, that can bind to a cyclic peptide comprising the amino acid sequence SNK, wherein the K (Lysine) is solvent-accessible and methods of treating and/or preventing amyloid-beta associated diseases such as Alzheimer's disease.
    Type: Application
    Filed: February 3, 2015
    Publication date: January 12, 2017
    Inventors: Cory Nykiforuk, Darrell Johnstone, Neil Cashman
  • Patent number: 9505847
    Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: November 29, 2016
    Assignee: CNJ HOLDINGS INC
    Inventors: Robyn Cassan, Jody Berry, Darrell Johnstone, Derek Toth, Joyee Antony George, Bonnie Tighe
  • Publication number: 20150290319
    Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin B. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.
    Type: Application
    Filed: November 29, 2013
    Publication date: October 15, 2015
    Inventors: Jody Berry, Robyn Cassan, Darrell Johnstone, Laura Saward, Joyee Antony George
  • Publication number: 20140127215
    Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a vertebrate subject are provided. The methods provide administering a composition to the vertebrate subject in an amount effective to reduce or eliminate or prevent relapse of Clostridium difficile bacterial infection and/or induce an immune response to the protein. Methods for the treatment or prevention of Clostridium difficile infection in a vertebrate are also provided.
    Type: Application
    Filed: December 29, 2011
    Publication date: May 8, 2014
    Applicant: CANGENE CORPORATION
    Inventors: Jody Berry, Darrell Johnstone, Bonnie Tighe, Marianela Lopez, Joyee George, Xiaobing Han
  • Publication number: 20140004118
    Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.
    Type: Application
    Filed: August 22, 2012
    Publication date: January 2, 2014
    Applicant: CANGENE CORPORATION
    Inventors: Robyn Cassan, Jody Berry, Darrell Johnstone, Derek Toth